Insilico Medicine 4 may 2026 Insilico Medicine to Present Groundbreaking AI Retrosynthesis Research at ICML 2026: Introducing ChemCensor to Bring Real-World Chemistry Into AI Benchmarking - Insilico Medicine
Endpoints News 4 may 2026 Windward Bio gets $165M to take China-derived drug into Phase 3 asthma trial
Amgen 4 may 2026 Amgen channels another $300M into US outlay, bolstering Puerto Rico biologics expansion - Fierce Pharma
Thermo Fisher 4 may 2026 Thermo Fisher Introduces Gibco CTS DynaXS Single Use Bioreactor For Scalable Cell Therapy Manufacturing - BioPharma APAC
FierceBiotech 4 may 2026 Celcuity’s gedatolisib beats Novartis’ Piqray in phase 3 breast cancer study
Thermo Fisher 4 may 2026 Thermo Fisher Scientific Unveils an Integrated Platform to Advance Scalable Cell Therapy Manufacturing - The Joplin Globe